Today: 12 May 2026
AMD Stock Pulls Back From Record High as BofA, Stifel Raise Targets on AI CPU Boom

AMD Stock Pulls Back From Record High as BofA, Stifel Raise Targets on AI CPU Boom

New York, April 20, 2026, 11:36 EDT

Advanced Micro Devices slipped Monday, cooling a bit after its record-breaking surge last week. Still, analysts at Bank of America and Stifel bumped up their price targets, keeping the spotlight on the chipmaker’s AI infrastructure story. Late in the New York morning, AMD traded at $274.61, off 1.4% from Friday’s $278.39 close.

Timing is key here. AMD drops its first-quarter results on May 5, just as more analysts start to debate whether AI investment is spilling over from graphics chips into CPUs—the workhorse processors that run servers and increasingly take on AI tasks.

Morgan Stanley on Monday pointed to “agentic AI” — the kind of artificial intelligence that can plan and execute tasks independently — as a driver set to boost demand for CPUs and memory chips, not just GPUs. That opens the door for AMD and Intel to carve out bigger roles in the coming wave of chip spending, moving beyond Nvidia’s current grip on AI-focused GPUs. Even so, renewed U.S.-Iran tensions weighed on the Nasdaq that day. Reuters

On April 18, Bank of America’s Vivek Arya bumped his AMD price target up to $310, from $280, sticking with a buy call. Arya pointed to CPUs now playing “an integral part of overall AI infrastructure.” He estimated that every gigawatt of installed capacity could mean $15 billion to $20 billion in net revenue for AMD, projecting this could push data-center growth above 60% year over year in both 2026 and 2027. TheStreet

On Monday, Stifel bumped its price target up to $320 from $280 and kept its buy rating in place, market data services and Yahoo Finance’s analyst tracker show. Sell-side forecasts continued to climb, with only two weeks left before AMD’s earnings release.

It’s been a blistering run. Barron’s noted AMD ended Thursday at a record-high $278.26—marking 12 sessions up in a row, the longest streak since 2005—after Bernstein bumped its target to $265 from $235 but stuck with a market-perform call. On Friday, AMD inched even higher, closing at $278.39, according to live market data.

Meta plays a significant role here. Back in February, AMD and Meta announced they would broaden their partnership, rolling out as much as 6 gigawatts of AMD Instinct GPUs. First shipments—enough to cover one gigawatt—are expected to hit in the second half of 2026. Over five years, Reuters put the deal’s value at up to $60 billion, with a warrant attached that could hand Meta up to 10% of AMD’s stock.

Analysts aren’t just seeing a revenue bump in that deal. Matt Britzman at Hargreaves Lansdown pointed out Meta is “locking in supply” and not relying on just one vendor. TD Cowen’s Joshua Buchalter called server CPUs “indispensable assets” with agentic AI rolling out across more data centers. Reuters

AMD is coming off a solid performance. The chipmaker posted record fourth-quarter revenue of $10.3 billion, while full-year 2025 sales climbed 34% to $34.6 billion. First-quarter 2026 results are set for release after the bell on May 5.

Risks remain. Bank of America pointed to several: execution hurdles for AMD’s debut rack-scale MI400 products, uncertainty around Middle East AI project timing and scope, shaky consumer and enterprise demand, dependence on a single manufacturing partner, and a maturing game-console cycle. Reuters, meanwhile, noted renewed Iran tensions were dragging U.S. stocks from record levels and sending oil higher.

Bullish bets have spilled beyond brokerages. Over the weekend, a Seeking Alpha post laid out a $600 target for AMD. Still, shares are moving somewhere between Bernstein’s $265 call and the higher $310-$320 range set by Bank of America and Stifel—underscoring just how scattered views are with May 5 approaching.

Stock Market Today

  • Wall Street Slides as AI Stocks Falter and Oil Prices Rise Amid Iran Conflict
    May 12, 2026, 5:23 PM EDT. Wall Street paused its record-setting rally as AI stocks declined and oil prices climbed amid tensions with Iran. The S&P 500 dropped 0.2% from its previous high, while the Nasdaq slipped 0.7%. Dow Jones Industrial Average rose slightly by 56 points. Significant losses hit chipmakers: Intel fell 6.8%, Micron Technology 3.6%, trimming strong year-to-date gains. South Korea's Kospi also dropped 2.3%, spooked by potential AI profit redistribution. Brent crude surged 3.4% to $107.77 a barrel due to Strait of Hormuz restrictions from the Iran war. Rising oil costs worsened U.S. inflation, surpassing forecasts, with Treasury yields climbing to 4.45%. Investors anticipate the Federal Reserve may maintain or hike interest rates amid persistent inflation concerns.

Latest article

Tesla Stock Falls as Hot Inflation and Robotaxi Doubts Test the AI Premium

Tesla Stock Falls as Hot Inflation and Robotaxi Doubts Test the AI Premium

12 May 2026
Tesla shares fell 2.7% to $433.45 after U.S. inflation data pushed Treasury yields higher and Reuters reported long waits and spotty robotaxi service in Texas. The stock swung from a high of $447.56 to a low of $422.39. Tesla’s valuation remains near $1.53 trillion, with a price-to-earnings ratio close to 398. Management cited cautious robotaxi rollout and increased 2026 capital spending above $25 billion.
Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

12 May 2026
Ernexa Therapeutics shares jumped 58.5% to $11.43 Tuesday after renewed investor focus on its preclinical ovarian-cancer therapy ERNA-101, following a May 11 investor event. Trading volume reached about 18.85 million shares. The company reported $8.3 million in cash as of April 30, less than needed for its 12-month plan, and may use an at-the-market stock sale to raise funds.
UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

12 May 2026
UnitedHealth shares climbed 3.1% to $396.45 Tuesday after unveiling a new Optum Rx fee-based pricing model and raising 2026 profit guidance. The company reported Q1 revenue of $111.7 billion and adjusted earnings of $7.23 per share. Management said fundamentals are improving but described the turnaround as ongoing. Investors responded to both the PBM overhaul and stronger earnings outlook.
Intel Stock Pulls Back From 25-Year High Ahead of Earnings as AI CPU Bet Faces Test
Previous Story

Intel Stock Pulls Back From 25-Year High Ahead of Earnings as AI CPU Bet Faces Test

Microsoft Stock Faces a Make-or-Break Earnings Test as Wall Street Splits on AI Spending
Next Story

Microsoft Stock Faces a Make-or-Break Earnings Test as Wall Street Splits on AI Spending

Go toTop